Table of Contents

1 Study Coverage

• 1.1 Self-Injections Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Self-Injections Market Size Growth Rate by Product
  • 1.4.2 Syringe Without Needle
  • 1.4.3 Automatic Syringe
  • 1.4.4 Pen Type Syringe
  • 1.4.5 Wearable Syringe
• 1.5 Market by End User
  • 1.5.1 Global Self-Injections Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Pharmaceutical Companies
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Self-Injections Market Size
  • 2.1.1 Global Self-Injections Revenue 2014-2025
  • 2.1.2 Global Self-Injections Sales 2014-2025
• 2.2 Self-Injections Growth Rate by Regions
  • 2.2.1 Global Self-Injections Sales by Regions
  • 2.2.2 Global Self-Injections Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Self-Injections Sales by Manufacturers
  • 3.1.1 Self-Injections Sales by Manufacturers
  • 3.1.2 Self-Injections Sales Market Share by Manufacturers
  • 3.1.3 Global Self-Injections Market Concentration Ratio (CR5 and HHI)
• 3.2 Self-Injections Revenue by Manufacturers
  • 3.2.1 Self-Injections Revenue by Manufacturers (2014-2019)
  • 3.2.2 Self-Injections Revenue Share by Manufacturers (2014-2019)
• 3.3 Self-Injections Price by Manufacturers
• 3.4 Self-Injections Manufacturing Base Distribution, Product Types
  • 3.4.1 Self-Injections Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Self-Injections Product Type
  • 3.4.3 Date of International Manufacturers Enter into Self-Injections Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Self-Injections Sales by Product
• 4.2 Global Self-Injections Revenue by Product
• 4.3 Self-Injections Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Self-Injections Breakdown Data by End User

6 North America

• 6.1 North America Self-Injections by Countries
  • 6.1.1 North America Self-Injections Sales by Countries
  • 6.1.2 North America Self-Injections Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Self-Injections by Product
• 6.3 North America Self-Injections by End User

7 Europe

• 7.1 Europe Self-Injections by Countries
  • 7.1.1 Europe Self-Injections Sales by Countries
  • 7.1.2 Europe Self-Injections Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Self-Injections by Product
• 7.3 Europe Self-Injections by End User

8 Asia Pacific

• 8.1 Asia Pacific Self-Injections by Countries
  • 8.1.1 Asia Pacific Self-Injections Sales by Countries
  • 8.1.2 Asia Pacific Self-Injections Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Self-Injections by Product
• 8.3 Asia Pacific Self-Injections by End User

9 Central & South America

• 9.1 Central & South America Self-Injections by Countries
  • 9.1.1 Central & South America Self-Injections Sales by Countries
  • 9.1.2 Central & South America Self-Injections Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Self-Injections by Product
• 9.3 Central & South America Self-Injections by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Self-Injections by Countries
  • 10.1.1 Middle East and Africa Self-Injections Sales by Countries
  • 10.1.2 Middle East and Africa Self-Injections Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Self-Injections by Product
• 10.3 Middle East and Africa Self-Injections by End User

11 Company Profiles

• 11.1 Elcam Medicalcompany Overview
  • 11.1.1 Elcam Medicalcompany Overview Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Elcam Medicalcompany Overview Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Elcam Medicalcompany Overview Self-Injections Products Offered
  • 11.1.5 Elcam Medicalcompany Overview Recent Development
• 11.2 Bespak
  • 11.2.1 Bespak Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bespak Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bespak Self-Injections Products Offered
  • 11.2.5 Bespak Recent Development
• 11.3 Sanofi
  • 11.3.1 Sanofi Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Sanofi Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Sanofi Self-Injections Products Offered
  • 11.3.5 Sanofi Recent Development
• 11.4 Sandoz International Gmbh
  • 11.4.1 Sandoz International Gmbh Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sandoz International Gmbh Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sandoz International Gmbh Self-Injections Products Offered
  • 11.4.5 Sandoz International Gmbh Recent Development
• 11.5 Unilife Corporation
  • 11.5.1 Unilife Corporation Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Unilife Corporation Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Unilife Corporation Self-Injections Products Offered
  • 11.5.5 Unilife Corporation Recent Development
• 11.6 West Pharmaceutical Services
  • 11.6.1 West Pharmaceutical Services Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 West Pharmaceutical Services Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 West Pharmaceutical Services Self-Injections Products Offered
  • 11.6.5 West Pharmaceutical Services Recent Development
• 11.7 Pfizer
  • 11.7.1 Pfizer Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Pfizer Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Pfizer Self-Injections Products Offered
  • 11.7.5 Pfizer Recent Development
• 11.8 Impax Laboratories
  • 11.8.1 Impax Laboratories Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Impax Laboratories Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Impax Laboratories Self-Injections Products Offered
  • 11.8.5 Impax Laboratories Recent Development
• 11.9 Penjet Corporation
  • 11.9.1 Penjet Corporation Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Penjet Corporation Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Penjet Corporation Self-Injections Products Offered
  • 11.9.5 Penjet Corporation Recent Development
• 11.10 Crossject Needle-Free Injection Systems
  • 11.10.1 Crossject Needle-Free Injection Systems Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Crossject Needle-Free Injection Systems Self-Injections Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Crossject Needle-Free Injection Systems Self-Injections Products Offered
  • 11.10.5 Crossject Needle-Free Injection Systems Recent Development
• 11.11 Wilhelm Haselmeier Gmbh & Co. Kg
• 11.12 Antares Pharma
• 11.13 Becton
• 11.14 Gerresheimer Ag
• 11.15 Mylan N.V
• 11.16 Novo Nordisk
• 11.17 Owen Mumford
• 11.18 Pharmajet
• 11.19 Shl Group
• 11.20 Ypsomed
• 11.21 Dickinson And Company

12 Future Forecast

• 12.1 Self-Injections Market Forecast by Regions
  • 12.1.1 Global Self-Injections Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Self-Injections Revenue Forecast by Regions 2019-2025
• 12.2 Self-Injections Market Forecast by Product
  • 12.2.1 Global Self-Injections Sales Forecast by Product 2019-2025
  • 12.2.2 Global Self-Injections Revenue Forecast by Product 2019-2025
• 12.3 Self-Injections Market Forecast by End User
• 12.4 North America Self-Injections Forecast
• 12.5 Europe Self-Injections Forecast
• 12.6 Asia Pacific Self-Injections Forecast
• 12.7 Central & South America Self-Injections Forecast
• 12.8 Middle East and Africa Self-Injections Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Self-Injections Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Self-Injections market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Self-Injections market based on company, product type, end user and key regions.

This report studies the global market size of Self-Injections in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Self-Injections in these regions.
This research report categorizes the global Self-Injections market by top players/brands, region, type and end user. This report also studies the global Self-Injections market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Elcam Medicalcompany Overview
Bespak
Sanofi
Sandoz International Gmbh
Unilife Corporation
West Pharmaceutical Services
Pfizer
Impax Laboratories
Penjet Corporation
Crossject Needle-Free Injection Systems
Wilhelm Haselmeier Gmbh & Co. Kg
Antares Pharma
Becton
Gerresheimer Ag
Mylan N.V
Novo Nordisk
Owen Mumford
Pharmajet
Shl Group
Ypsomed
Dickinson And Company

Market size by Product
Syringe Without Needle
Automatic Syringe
Pen Type Syringe
Wearable Syringe
Market size by End User
Hospital
Clinic
Pharmaceutical Companies
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Self-Injections market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Self-Injections market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Self-Injections companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Self-Injections submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Self-Injections are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Self-Injections market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.